ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
0.9467
+0.0357 (3.92%)
Apr 25, 2025, 4:00 PM EDT - Market closed
ABVC BioPharma Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for ABVC BioPharma.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for ABVC BioPharma.
Recommendation Trends
Rating | Nov '22 |
---|---|
Strong Buy | 0 |
Buy | 0 |
Hold | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 16, 2022 |
Financial Forecast
Revenue This Year
4.26M
from 509.59K
Increased by 735.18%
Revenue Next Year
n/a
from 4.26M
EPS This Year
-0.47
from -0.42
EPS Next Year
n/a
from -0.47
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 |
---|---|
High | 4.4M |
Avg | 4.3M |
Low | 4.1M |
Revenue Growth
Revenue Growth | 2025 |
---|---|
High | 759.9% |
Avg | 735.2% |
Low | 702.6% |
EPS Forecast
EPS | 2025 |
---|---|
High | -0.48 |
Avg | -0.47 |
Low | -0.45 |
EPS Growth
EPS Growth | 2025 |
---|---|
High | - |
Avg | - |
Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.